Safety and efficacy of oral TLR8 agonist, selgantolimod, in viremic adult patients with chronic hepatitis B

被引：0

作者：

Janssen, Harry L. A. ^{[1
]}

Lim, Young-Suk ^{[2
]}

Kim, Hyung Joon ^{[3
]}

Tseng, Cheng-Hao ^{[4
]}

Coffin, Carla S. ^{[5
]}

Elkashab, Magdy ^{[6
]}

Ahn, Sang Hoon ^{[7
]}

Anh-Hoa Nguyen ^{[8
]}

Chen, Diana ^{[8
]}

Wallin, Jeffrey ^{[8
]}

Tan, Susanna ^{[8
]}

Yang, Jenny ^{[8
]}

Gaggar, Anuj ^{[8
]}

Brainard, Diana ^{[8
]}

Fung, Scott ^{[1
]}

Kim, Yoon Jun ^{[9
,10
]}

Kao, Jia-Horng ^{[11
]}

Chuang, Wan-Long ^{[12
]}

Brooks, Anna ^{[13
,14
]}

Dunbar, P. Rod ^{[13
,14
]}

机构：

[1] Univ Hlth Network, Toronto Gen Hosp Res Inst, Toronto Ctr Liver Dis, Toronto, ON, Canada

[2] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea

[3] Chung Ang Univ, Coll Med, Seoul, South Korea

[4] E Da Hosp, Kaohsiung, Taiwan

[5] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada

[6] Toronto Liver Ctr, Toronto, ON, Canada

[7] Yonsei Univ, Coll Med, Seoul, South Korea

[8] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[9] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

[10] Seoul Natl Univ Hosp, Liver Res Inst, Seoul, South Korea

[11] Natl Taiwan Univ Hosp, Taipei, Taiwan

[12] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan

[13] Univ Auckland, Sch Biol Sci, Auckland, New Zealand

[14] Univ Auckland, Maurice Wilkins Ctr Auckland, Auckland, New Zealand

来源：

JOURNAL OF HEPATOLOGY | 2021年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PO-2429

引用

页码：S757 / S758

页数：2

共 50 条

[21] EFFICACY AND SAFETY OF TELBIVUDINE IN PREGNANT CHRONIC HEPATITIS B PATIENTS
Zhou Yuejin
Zheng Jinli
Pan Huajiang
Jiang Shan
[J]. HEPATOLOGY, 2011, 54 : 1015A - 1016A
[22] Follicular Helper T (TFH) Cell Targeting by TLR8 Signaling For Improving HBsAg-Specific B Cell Response In Chronic Hepatitis B Patients
Ayithan, Natarajan
Tang, Lydia
Tan, Susanna K.
Chen, Diana
Wallin, Jeffrey J.
Fletcher, Simon P.
Kottilil, Shyam
Poonia, Bhawna
[J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
[23] Extended treatment of chronic hepatitis B with oral lobucavir; Safety and efficacy.
Bloomer, J
Brennan-Rowe, N
Denisky, G
Bukenya, T
Rutkiewicz, V
Joshi, S
DeHertogh, D
[J]. HEPATOLOGY, 1998, 28 (04) : 486A - 486A
[24] Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection
de Man, RA
Wolters, LMM
Nevens, F
Chua, D
Sherman, M
Lai, CL
Gadano, A
Lee, Y
Mazzotta, F
Thomas, N
DeHertogh, D
[J]. HEPATOLOGY, 2001, 34 (03) : 578 - 582
[25] The TLR8 agonist Selgantolimod modulates Kupffer cell differentiation status and indirectly impairs HBV entry into hepatocytes via an IL-6-dependent mechanism
Suarez, Armando Andres Roca
Plissonnier, Marie-Laure
Grand, Xavier
Michelet, Maud
Giraud, Guillaume
Fletcher, Simon
Rivoire, Michel
Testoni, Barbara
Levrero, Massimo
Zoulim, Fabien
[J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S1014 - S1015
[26] EFFICACY AND SAFETY OF TELBIVUDINE USE IN HIGHLY VIREMIC MOTHERS WITH HBEAG plus CHRONIC HEPATITIS B (CHB) IN CLINICAL PRACTICE
Han, G.
Jiang, H.
Zhao, W.
Ge, C.
Xu, C.
[J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S202 - S202
[27] EFFICACY AND SAFETY OF LAMIVUDINE USE IN HIGHLY VIREMIC MOTHERS WITH HBEAG plus CHRONIC HEPATITIS B (CHB) IN CLINICAL PRACTICE
Pan, Calvin
Han, Guo Rong
Jiang, Hong Xiu
Ge, Chun Yan
Xu, Chuan Lu
Zhao, Wei
[J]. HEPATOLOGY, 2011, 54 : 881A - 882A
[28] The impact of cirrhosis on the efficacy and safety of entecavir for patients with chronic hepatitis B
Huang, Rui
Wang, Jian
Zhao, Xiang-An
Xia, Juan
Wu, Chao
[J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (11) : 1314 - 1314
[29] Safety and efficacy of alamifovir in patients with chronic hepatitis B virus infection
Soon, DKW
Lowe, SL
Teng, CH
Yeo, KP
McGill, J
Wise, SD
[J]. JOURNAL OF HEPATOLOGY, 2004, 41 (05) : 852 - 858
[30] Clinical Efficacy and Safety of Tenofovir in the Treatment of Patients with Chronic Hepatitis B
He, Feng
Xia, Zhongjiang
Wang, Hui
Zhu, Jinjun
Hu, Laiwen
[J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022

← 1 2 3 4 5 →